Elevance Health (ELV)
NYSE:ELV
Want to see ELV full AI Analyst Report?
ELV Stock Chart & Stats
$323.05
<$0.01(<0.01%)
At close: 4:00 PM EST
$323.05
<$0.01(<0.01%)
Day’s Range― - ―
52-Week Range$273.71 - $424.24
Previous CloseN/A
Volume477.50K
Average Volume (3M)1.69M
Market Cap
$80.93B
Enterprise Value$103.12B
Total Cash (Recent Filing)$35.56B
Total Debt (Recent Filing)$31.84B
Price to Earnings (P/E)9.1
Beta0.44
Next Earnings
Jul 22, 2026EPS Estimate
6.2Next Dividend Ex-DateN/A
Dividend Yield1.99%
Share Statistics
EPS (TTM)23.51
Shares Outstanding217,162,380
10 Day Avg. Volume1,509,129
30 Day Avg. Volume1,686,804
Financial Highlights & Ratios
PEG Ratio-5.63
Price to Book (P/B)1.77
Price to Sales (P/S)0.39
P/FCF Ratio24.50
Enterprise Value/Market Cap1.27
Enterprise Value/Revenue0.51
Enterprise Value/Gross Profit2.22
Enterprise Value/Ebitda11.56
Forecast
1Y Price Target
$386.47Price Target Upside19.63% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering16
EPS Forecast (FY)26.79
Revenue Forecast (FY)$194.66B
Bulls Say, Bears Say
Bulls Say
Carelon External GrowthIncreased investments in Carelon and strong external business growth excluding member declines point to revenue diversification opportunities beyond core membership trends.
Guidance And CredibilityManagement's conservative earnings guidance establishes a cautious baseline that enhances credibility and creates room for upside if margins improve.
Leadership And GovernanceHiring an experienced Chief Growth and Strategy Officer combined with a leadership reorganization that places Health Benefits and Carelon under dedicated, seasoned executives strengthens strategic oversight and execution.
Bears Say
At-risk Cost ExposureCarelon's acceptance of at-risk responsibility for large blocks of medical costs in fast-rising cost areas raises financial exposure and potential earnings volatility.
Medicaid Profitability PressureA high concentration of at-risk business tied to Medicaid and a shrinking Medicaid population pressure underwriting margins and reduce overall earnings power.
Membership And Revenue RiskDeliberate pricing actions and guidance signaling declines in Medicare Advantage and exchange memberships risk driving revenue declines and weakening near-term growth for the insurer.
Elevance Health News
ELV FAQ
What was Elevance Health’s price range in the past 12 months?
Elevance Health lowest stock price was $273.71 and its highest was $424.24 in the past 12 months.
What is Elevance Health’s market cap?
Elevance Health’s market cap is $80.93B.
When is Elevance Health’s upcoming earnings report date?
Elevance Health’s upcoming earnings report date is Jul 22, 2026 which is in 79 days.
How were Elevance Health’s earnings last quarter?
Elevance Health released its earnings results on Apr 22, 2026. The company reported $12.58 earnings per share for the quarter, beating the consensus estimate of $11.033 by $1.547.
Is Elevance Health overvalued?
According to Wall Street analysts Elevance Health’s price is currently Undervalued.
Does Elevance Health pay dividends?
Elevance Health pays a Quarterly dividend of $1.71 which represents an annual dividend yield of 1.99%. See more information on Elevance Health dividends here
What is Elevance Health’s EPS estimate?
Elevance Health’s EPS estimate is 6.2.
How many shares outstanding does Elevance Health have?
Elevance Health has 217,162,380 shares outstanding.
What happened to Elevance Health’s price movement after its last earnings report?
Elevance Health reported an EPS of $12.58 in its last earnings report, beating expectations of $11.033. Following the earnings report the stock price went up 0.027%.
Which hedge fund is a major shareholder of Elevance Health?
Currently, no hedge funds are holding shares in ELV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Elevance Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$386.47 (19.63% Upside)
$386.47 (19.63% Upside)
Blogger Sentiment
Bullish
ELV Sentiment 92%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 895.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $48.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.3%
Last 30 Days ▲ 3.4%
Last 30 Days ▲ 3.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.27%
12-Months-Change
Fundamentals
Return on Equity
11.95%
Trailing 12-Months
Asset Growth
5.10%
Trailing 12-Months
Company Description
Elevance Health
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
ELV Company Deck
ELV Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized strong execution and tangible operational improvements that drove a Q1 EPS beat, an upgraded full-year EPS guide, share repurchases and growing demand for integrated clinical and pharmacy offerings. Management also highlighted meaningful AI investments and measurable clinical results from Carelon/CareBridge (20% readmission reduction, >10% post-acute savings). Offsetting these positives are a material $935 million accrual related to a CMS historical risk-adjustment matter, a $129 million optimization charge, ongoing elevated Medicaid cost trends and some margin pressure and investment-driven cadence at Carelon. On balance the positives (guidance raise, underlying business beats, membership growth, cash generation and scalable AI/Carelon proof points) outweigh the negatives (one-time accrual, Medicaid pressure, Carelon margin timing), supporting a constructive outlook with manageable risks.View all ELV earnings summariesELV Stock 12 Month Forecast
Average Price Target
$386.47
▲(19.63% Upside)
Technical Analysis
Ownership Overview
0.17% Insiders
28.46% Mutual Funds
3.92% Other Institutional Investors
41.69% Public Companies and Individual Investors